Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers

GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers

US Patent 12473354 · Granted Nov 18, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-GDF15 antibody and a dosage regimen for the treatment of cancer2025
Anti-GDF15 antibody and a dosage regimen for the treatment of cancer2025
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)2024
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses2023
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses2023
Combination therapy using inhibitors of human growth and differentiation factor 2022
Combination therapy using inhibitors of human growth and differentiation factor 2022
Combination therapy using inhibitors of human growth and differentiation factor 2022
Combination therapy using inhibitors of human growth and differentiation factor 2022
GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment wit2022
GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment wit2022
GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment wit2022